Transcriptional regulation in pluripotent stem cells by methyl CpG-binding protein 2 (MeCP2)

Human Molecular Genetics

Volumn 23, Issue 4, 2014, Pages 1045-1055

  Tanaka, Yoshiaki ^a   Kim, Kun Yong ^a   Zhong, Mei ^a   Pan, Xinghua ^a   Weissman, Sherman Morton ^a   Park, In Hyun ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2; NOTCH1 RECEPTOR; TRANSCRIPTOME;

ARTICLE; AUTOSOME; CELL MUTANT; CHROMOSOME 8; CONTROLLED STUDY; EMBRYONIC STEM CELL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; METHYL CPG BINDING PROTEIN 2 GENE; MITOCHONDRIAL MEMBRANE; NERVE CELL; NERVE CELL DIFFERENTIATION; PLURIPOTENT STEM CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETT SYNDROME; RNA ANALYSIS; RNA SEQUENCE; SYNAPTIC TRANSMISSION; TRANSCRIPTION REGULATION; UPREGULATION; WILD TYPE; X CHROMOSOME; X CHROMOSOME INACTIVATION;

CELLS, CULTURED; EMBRYONIC STEM CELLS; FEMALE; GENE EXPRESSION REGULATION; GENE ONTOLOGY; HUMANS; INDUCED PLURIPOTENT STEM CELLS; METHYL-CPG-BINDING PROTEIN 2; MUTATION; RETT SYNDROME; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

EID: 84892952870     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt500     Document Type: Article

References (52)

1. Gadalla, K.K., Bailey, M.E. and Cobb, S.R. (2011) MeCP2 and Rett syndrome: reversibility and potential avenues for therapy. Biochem. J., 439, 1-14.
2. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U. and Zoghbi, H.Y. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet., 23, 185-188.
3. Chen, W.G., Chang, Q., Lin, Y., Meissner, A., West, A.E., Griffith, E.C., Jaenisch, R. and Greenberg, M.E. (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science, 302, 885-889.
4. Horike, S., Cai, S., Miyano, M., Cheng, J.F. and Kohwi-Shigematsu, T. (2005) Loss of silent-chromatin looping and impaired imprinting ofDLX5in Rett syndrome. Nat. Genet., 37, 31-40.
5. Chao, H.T., Zoghbi, H.Y. and Rosenmund, C. (2007) MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron, 56, 58-65.
6. Samaco, R.C., Mandel-Brehm, C., McGraw, C.M., Shaw, C.A., McGill, B.E. and Zoghbi, H.Y. (2012) Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome. Nat. Genet., 44, 206-211.
7. Nan, X., Ng, H.H., Johnson, C.A., Laherty, C.D., Turner, B.M., Eisenman, R.N. and Bird, A. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393, 386-389.
8. Jones, P.L., Veenstra, G.J., Wade, P.A., Vermaak, D., Kass, S.U., Landsberger, N., Strouboulis, J. and Wolffe, A.P. (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet., 19, 187-191.
9. Chahrour, M., Jung, S.Y., Shaw, C., Zhou, X., Wong, S.T., Qin, J. and Zoghbi, H.Y. (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science, 320, 1224-1229.
10. Yasui, D.H., Peddada, S., Bieda, M.C., Vallero, R.O., Hogart, A., Nagarajan, R.P., Thatcher, K.N., Farnham, P.J. and Lasalle, J.M. (2007) Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc. Natl Acad. Sci.USA, 104, 19416-19421.
11. Young, J.I., Hong, E.P., Castle, J.C., Crespo-Barreto, J., Bowman, A.B., Rose, M.F., Kang, D., Richman, R., Johnson, J.M., Berget, S. et al. (2005) Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2. Proc. Natl Acad. Sci. USA, 102, 17551-17558.
12. Samaco, R.C., Hogart, A. and LaSalle, J.M. (2005) Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum. Mol. Genet., 14, 483-492.
13. Squillaro, T., Alessio, N., Cipollaro, M., Renieri, A., Giordano, A. and Galderisi, U. (2010) Partial silencing of methyl cytosine protein binding 2 (MECP2) in mesenchymal stem cells induces senescence with an increase in damaged DNA. FASEB J., 24, 1593-1603.
14. Yu, F., Zingler, N., Schumann, G. and Strätling, W.H. (2001) Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription. Nucleic Acids Res., 29, 4493-4501.
15. Muotri, A.R., Marchetto, M.C., Coufal, N.G., Oefner, R., Yeo, G., Nakashima, K. and Gage, F.H. (2010) L1 retrotransposition in neurons is modulated by MeCP2. Nature, 468, 443-446.
16. Wutz, A. (2011) Gene silencing in X-chromosome inactivation: advances in understanding facultative heterochromatin formation. Nat. Rev. Genet., 12, 542-553.
17. Silva, S.S., Rowntree, R.K., Mekhoubad, S. and Lee, J.T. (2008) X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc. Natl Acad. Sci. USA, 105, 4820-4825.
18. Kim, K.Y., Hysolli, E. and Park, I.H. (2011) Neuronal maturation defect in induced pluripotent stem cells from patients with Rett syndrome. Proc. Natl Acad. Sci. USA, 108, 14169-14174.
19. Tomoda, K., Takahashi, K., Leung, K., Okada, A., Narita, M., Yamada, N.A., Eilertson, K.E., Tsang, P., Baba, S., White, M.P. et al. (2012) Derivation conditions impact X-inactivation status in femalehumaninduced pluripotent stem cells. Cell Stem Cell, 11, 91-99.
20. Mekhoubad, S., Bock, C., de Boer, A.S., Kiskinis, E., Meissner, A. and Eggan, K. (2012) Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell, 10, 595-609.
21. Lengner, C.J., Gimelbrant, A.A., Erwin, J.A., Cheng, A.W., Guenther, M.G., Welstead, G.G., Alagappan, R., Frampton, G.M., Xu, P., Muffat, J. et al. (2010) Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell, 141, 872-883.
22. Saha, K. and Jaenisch, R. (2009) Technical challenges in using human induced pluripotent stem cells to model disease. Cell Stem Cell, 5, 584-595.
23. Park, I.H., Zhao, R., West, J.A., Yabuuchi, A., Huo, H., Ince, T.A., Lerou, P.H., Lensch, M.W. and Daley, G.Q. (2008) Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451, 141-146.
24. Takahashi, K. and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
25. Park, I.H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M.W., Cowan, C., Hochedlinger, K. and Daley, G.Q. (2008) Disease-specific induced pluripotent stem cells. Cell, 134, 877-886.
26. Jung, Y.W., Hysolli, E., Kim, K.Y., Tanaka, Y. and Park, I.H. (2012) Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies. Curr. Opin. Neurol., 25, 125-130.
27. Cheung, A.Y., Horvath, L.M., Grafodatskaya, D., Pasceri, P., Weksberg, R., Hotta, A., Carrel, L. and Ellis, J. (2011) Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum. Mol. Genet., 20, 2103-2115.
28. Pomp, O., Dreesen, O., Leong, D.F., Meller-Pomp, O., Tan, T.T., Zhou, F. and Colman, A. (2011) Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase. Cell Stem Cell, 9, 156-165.
29. Marchetto, M.C., Carromeu, C., Acab, A., Yu, D., Yeo, G.W., Mu, Y., Chen, G., Gage, F.H. and Muotri, A.R. (2010)Amodel for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell, 143, 527-539.
30. Maezawa, I., Swanberg, S., Harvey, D., LaSalle, J.M. and Jin, L.W. (2009) Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J. Neurosci., 29, 5051-5061.
31. Derecki, N.C., Cronk, J.C., Lu, Z., Xu, E., Abbott, S.B., Guyenet, P.G. and Kipnis, J. (2012) Wild-type microglia arrest pathology in a mouse model of Rett syndrome. Nature, 484, 105-109.
32. Plath, K., Fang, J., Mlynarczyk-Evans, S.K., Cao, R., Worringer, K.A., Wang, H., de la Cruz, C.C., Otte, A.P., Panning, B. and Zhang, Y. (2003) Role of histone H3 lysine 27 methylation in X inactivation. Science, 300, 131-135.
33. Lister, R., Pelizzola, M., Kida, Y.S., Hawkins, R.D., Nery, J.R., Hon, G., Antosiewicz-Bourget, J., O'Malley, R., Castanon, R., Klugman, S. et al. (2011) Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature, 471, 68-73.
34. Kriaucionis, S., Paterson, A., Curtis, J., Guy, J., Macleod, N. and Bird, A. (2006) Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome. Mol. Cell Biol., 26, 5033-5042.
35. Deng, V., Matagne, V., Banine, F., Frerking, M., Ohliger, P., Budden, S., Pevsner, J., Dissen, G.A., Sherman, L.S. and Ojeda, S.R. (2007) FXYD1 Is an MeCP2 target gene overexpressed in the brains of rett syndrome patients and Mecp2-null mice. Hum. Mol. Genet., 16, 640-650.
36. Ross, M.T., Grafham, D.V., Coffey, A.J., Scherer, S., McLay, K., Muzny,D., Platzer, M., Howell, G.R., Burrows, C., Bird, C.P. et al. (2005) The DNA sequence of the human X chromosome. Nature, 434, 325-337.
37. Wang, T., Wu, H., Li, Y., Szulwach, K.E., Lin, L., Li, X., Chen, I.P., Goldlust, I.S., Chamberlain, S.J., Dodd, A. et al. (2013) Subtelomeric hotspots of aberrant 5-hydroxymethylcytosine-mediated epigenetic modifications during reprogramming to pluripotency. Nat. Cell Biol., 15, 700-711.
38. Carrel, L. and Willard, H.F. (2005) X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature, 434, 400-404.
39. Neul, J.L., Fang, P., Barrish, J., Lane, J., Caeg, E.B., Smith, E.O., Zoghbi, H., Percy, A. and Glaze, D.G. (2008) Specific mutations in methyl-CpG-bindingprotein 2 confer different severity in Rett syndrome. Neurology, 70, 1313-1321.
40. Mellén, M., Ayata, P., Dewell, S., Kriaucionis, S. and Heintz, N. (2012) MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell, 151, 1417-1430.
41. Szulwach, K.E., Li, X., Li, Y., Song, C.X., Han, J.W., Kim, S., Namburi, S., Hermetz, K., Kim, J.J., Rudd, M.K. et al. (2011) Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells. PLoS Genet., 7, e1002154.
42. Szulwach, K.E., Li, X., Li, Y., Song, C.X., Wu, H., Dai, Q., Irier, H., Upadhyay, A.K., Gearing, M., Levey, A.I. et al. (2011) 5-hmC-mediated Epigenetic dynamics during postnatal neurodevelopment and aging. Nat. Neurosci., 14, 1607-1616.
43. Zhou, Z., Hong, E.J., Cohen, S., Zhao, W.N., Ho, H.Y., Schmidt, L., Chen, W.G., Lin, Y., Savner, E., Griffith, E.C. et al. (2006) Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron, 52, 255-269.
44. Cukier, H.N., Perez, A.M., Collins, A.L., Zhou, Z., Zoghbi, H.Y. and Botas, J. (2008) Genetic modifiers of MeCP2 function in Drosophila. PLoS Genet., 4, e1000179.
45. Tao, J., Hu, K., Chang, Q., Wu, H., Sherman, N.E., Martinowich, K., Klose, R.J., Schanen, C., Jaenisch, R., Wang, W. et al. (2009) Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. Proc. Natl Acad. Sci. USA, 106, 4882-4887.
46. Exner, N., Lutz, A.K., Haass, C. and Winklhofer, K.F. (2012) Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J., 31, 3038-3062.
47. Quintanilla, R.A. and Johnson, G.V. (2009) Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease. Brain Res. Bull., 80, 242-247.
48. Park, I.H., Lerou, P.H., Zhao, R., Huo, H. and Daley, G.Q. (2008) Generation of human-induced pluripotent stem cells. Nat. Protoc., 3, 1180-1186.
49. Tchieu, J., Kuoy, E., Chin, M.H., Trinh, H., Patterson, M., Sherman, S.P., Aimiuwu, O., Lindgren, A., Hakimian, S., Zack, J.A. et al. (2010) Female human iPSCs retain an inactive X chromosome. Cell Stem Cell, 7, 329-342.
50. Clemson, C.M., McNeil, J.A., Willard, H.F. and Lawrence, J.B. (1996)XIST RNA paints the inactive X chromosome at interphase: evidence for a novel RNA involved in nuclear/chromosome structure. J. Cell Biol., 132, 259-275.
51. Trapnell, C., Pachter, L. and Salzberg, S.L. (2009) Tophat: discovering splice junctions with RNA-Seq. Bioinformatics, 25, 1105-1111.
52. Trapnell, C., Williams, B.A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M.J., Salzberg, S.L., Wold, B.J. and Pachter, L. (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol., 28, 511-515.